Samuel D. Colella, Director, 10% Owner at Flexion Therapeutics Inc (FLXN), bought 33,333 shares at $18.00 ($600K) on 2016-11-21, disclosed to the SEC on 2016-11-22.
Open-market purchase of $600k FLXN by Director, 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade C.
Something here stands out, but not much.
| Filing → |
| FLDM | BUY | 2019-08-12 | $7K | — | Filing → |
| FLXN | BUY | 2019-08-09 | $21K | — | Filing → |
| FLDM | BUY | 2019-08-08 | $63K | — | Filing → |